BlackRock Institutional Trust’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $14.2M | Buy |
940,753
+104,002
| +12% | +$1.57M | ﹤0.01% | 2194 |
|
|
2016
Q3 | $12.8M | Buy |
836,751
+48,008
| +6% | +$732K | ﹤0.01% | 2185 |
|
|
2016
Q2 | $30.6M | Buy |
788,743
+67,349
| +9% | +$2.61M | 0.01% | 1556 |
|
|
2016
Q1 | $20.1M | Buy |
721,394
+35,196
| +5% | +$978K | ﹤0.01% | 1828 |
|
|
2015
Q4 | $36.9M | Buy |
686,198
+135,440
| +25% | +$7.29M | 0.01% | 1449 |
|
|
2015
Q3 | $22.1M | Buy |
550,758
+35,069
| +7% | +$1.4M | ﹤0.01% | 1770 |
|
|
2015
Q2 | $16.5M | Buy |
515,689
+54,965
| +12% | +$1.76M | ﹤0.01% | 2054 |
|
|
2015
Q1 | $11M | Buy |
460,724
+275,467
| +149% | +$6.58M | ﹤0.01% | 2336 |
|
|
2014
Q4 | $3.27M | Sell |
185,257
-1,204
| -0.6% | -$21.3K | ﹤0.01% | 2899 |
|
|
2014
Q3 | $2.56M | Sell |
186,461
-13,187
| -7% | -$181K | ﹤0.01% | 2961 |
|
|
2014
Q2 | $3.37M | Buy |
199,648
+193,554
| +3,176% | +$3.26M | ﹤0.01% | 2947 |
|
|
2014
Q1 | $111K | Buy |
+6,094
| New | +$111K | ﹤0.01% | 3739 |
|